{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T15:17:37Z","timestamp":1772983057037,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T00:00:00Z","timestamp":1408406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Health Prev Med"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12199-014-0403-9","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T01:07:21Z","timestamp":1408324041000},"page":"322-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Silica exposure and altered regulation of autoimmunity"],"prefix":"10.1007","volume":"19","author":[{"given":"Suni","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Kumagai-Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Yoshitome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozo","family":"Urakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumitsu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemi","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,19]]},"reference":[{"key":"403_CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4104\/pcrj.2013.00055","volume":"22","author":"P Cullinan","year":"2013","unstructured":"Cullinan P, Reid P. Pneumoconiosis. Prim Care Respir J. 2013;22:249\u201352.","journal-title":"Prim Care Respir J"},{"key":"403_CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ccm.2012.08.005","volume":"33","author":"AS Laney","year":"2012","unstructured":"Laney AS, Weissman DN. The classic pneumoconioses: new epidemiological and laboratory observations. Clin Chest Med. 2012;33:745\u201358.","journal-title":"Clin Chest Med"},{"key":"403_CR3","first-page":"226","volume":"19","author":"J Nukushina","year":"1995","unstructured":"Nukushina J. Japanese earthquake victims are being exposed to high density of asbestos. We need protective masks desperately. Epidemiol Prev. 1995;19:226\u20137.","journal-title":"Epidemiol Prev"},{"key":"403_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/rtph.1995.1016","volume":"21","author":"DR Orden van","year":"1995","unstructured":"van Orden DR, Lee RJ, Bishop KM, Kahane D, Morse R. Evaluation of ambient asbestos concentrations in buildings following the Loma Prieta earthquake. Regul Toxicol Pharmacol. 1995;21:117\u201322.","journal-title":"Regul Toxicol Pharmacol"},{"key":"403_CR5","first-page":"1111","volume":"52","author":"A Caplan","year":"1959","unstructured":"Caplan A. Rheumatoid disease and pneumoconiosis (Caplan\u2019s syndrome). Proc R Soc Med. 1959;52:1111\u20133.","journal-title":"Proc R Soc Med"},{"key":"403_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/thx.17.3.205","volume":"17","author":"A Caplan","year":"1962","unstructured":"Caplan A, Payne A, Payne RB, Withey JL. A broader concept of Caplan\u2019s syndrome related to rheumatoid factors. Thorax. 1962;17:205\u201312.","journal-title":"Thorax"},{"key":"403_CR7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1297-319X(01)00344-X","volume":"69","author":"LT Costallat","year":"2002","unstructured":"Costallat LT, De Capitani EM, Zambon L. Pulmonary silicosis and systemic lupus erythematosus in men: a report of two cases. Joint Bone Spine. 2002;69:68\u201371.","journal-title":"Joint Bone Spine"},{"key":"403_CR8","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2169\/internalmedicine.46.0015","volume":"46","author":"S Yamazaki","year":"2007","unstructured":"Yamazaki S, Yoshiike F, Hirai K, Kakegawa T, Ikeda M, Nagata A, et al. Silica-associated systemic lupus erythematosus in an elderly man. Intern Med. 2007;46:1867\u201371.","journal-title":"Intern Med"},{"key":"403_CR9","first-page":"1917","volume":"25","author":"UF Haustein","year":"1998","unstructured":"Haustein UF, Anderegg U. Silica induced scleroderma-clinical and experimental aspects. J Rheumatol. 1998;25:1917\u201326.","journal-title":"J Rheumatol"},{"key":"403_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s100670200019","volume":"21","author":"S Iannello","year":"2002","unstructured":"Iannello S, Camuto M, Cantarella S, Cavaleri A, Ferriero P, Leanza A, Milazzo P, Belfiore F. Rheumatoid syndrome associated with lung interstitial disorder in a dental technician exposed to ceramic silica dust. A case report and critical literature review. Clin Rheumatol. 2002;21:76\u201381.","journal-title":"Clin Rheumatol"},{"key":"403_CR11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00002281-199801000-00003","volume":"10","author":"JW Tervaert","year":"1998","unstructured":"Tervaert JW, Stegeman CA, Kallenberg CG. Silicon exposure and vasculitis. Curr Opin Rheumatol. 1998;10:12\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"403_CR12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10067-003-0815-1","volume":"23","author":"T Saeki","year":"2004","unstructured":"Saeki T, Fujita N, Kourakata H, Yamazaki H, Miyamura S. Two cases of hypertrophic pachymeningitis associated with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive pulmonary silicosis in tunnel workers. Clin Rheumatol. 2004;23:76\u201380.","journal-title":"Clin Rheumatol"},{"key":"403_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/10408448209003370","volume":"10","author":"CL Uber","year":"1982","unstructured":"Uber CL, McReynolds RA. Immunotoxicology of silica. Crit Rev Toxicol. 1982;10:303\u201319.","journal-title":"Crit Rev Toxicol"},{"key":"403_CR14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajim.4700280505","volume":"28","author":"K Steenland","year":"1995","unstructured":"Steenland K, Goldsmith DF. Silica exposure and autoimmune diseases. Am J Ind Med. 1995;28:603\u20138.","journal-title":"Am J Ind Med"},{"key":"403_CR15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1586\/eci.13.2","volume":"9","author":"O Vera-Lastra","year":"2013","unstructured":"Vera-Lastra O, Medina G, Del Pilar Cruz-Dominguez M, Jara LJ, Shoenfeld Y. Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld\u2019s syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol. 2013;9:361\u201373.","journal-title":"Expert Rev Clin Immunol"},{"key":"403_CR16","first-page":"261","volume":"4","author":"T Otsuki","year":"2007","unstructured":"Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M, Nishimura Y, et al. Immunological effects of silica and asbestos. Cell Mol Immunol. 2007;4:261\u20138.","journal-title":"Cell Mol Immunol"},{"key":"403_CR17","first-page":"11","volume":"2","author":"M Maeda","year":"2008","unstructured":"Maeda M, Miura Y, Nishimura Y, Murakami S, Hayashi H, Kumagai N, et al. Immunological changes in mesothelioma patients and their experimental detection. Clin Med Circ Respir Pulm Med. 2008;2:11\u20137.","journal-title":"Clin Med Circ Respir Pulm Med"},{"key":"403_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12199-007-0012-y","volume":"13","author":"Y Miura","year":"2008","unstructured":"Miura Y, Nishimura Y, Maeda M, Murakami S, Hayashi H, Fukuoka K, et al. Immunological alterations found in mesothelioma patients and supporting experimental evidence. Environ Health Prev Med. 2008;13:55\u20139.","journal-title":"Environ Health Prev Med"},{"key":"403_CR19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12199-008-0063-8","volume":"14","author":"S Murakami","year":"2009","unstructured":"Murakami S, Nishimura Y, Maeda M, Kumagai N, Hayashi H, Chen Y, et al. Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases. Environ Health Prev Med. 2009;14:216\u201322.","journal-title":"Environ Health Prev Med"},{"key":"403_CR20","unstructured":"ILO. Guideline for the use of the ILO international classification of radiographs of pneumoconiosis, Revised Edition 2000. ILO, Occupational Safety and Health series. No. 22. Geneva, Switzerland. 2002."},{"key":"403_CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/039463200601900212","volume":"19","author":"P Wu","year":"2006","unstructured":"Wu P, Miura Y, Hyodoh F, Nishimura Y, Hatayama T, Hatada S, et al. Reduced function of CD4\u00a0+\u00a025\u00a0+\u00a0regulatory T cell fraction in silicosis patients. Int J Immunopathol Pharmacol. 2006;19:357\u201368.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"403_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/039463200902200107","volume":"22","author":"H Hayashi","year":"2009","unstructured":"Hayashi H, Maeda M, Murakami S, Kumagai N, Chen Y, Hatayama T, et al. Soluble interleukin-2 receptor as an indicator of immunological disturbance found 388 in silicosis patients. Int J Immunopathol Pharmacol. 2009;22:53\u201362.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"403_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0048-9697(00)00792-0","volume":"270","author":"A Ueki","year":"2001","unstructured":"Ueki A, Isozaki Y, Tomokuni A, Tanaka S, Otsuki T, Kishimoto T, et al. Autoantibodies detectable in the sera of silicosis patients. The relationship between the anti-topoisomerase I antibody response and HLA-DQB1*0402 allele in Japanese silicosis patients. Sci Total Environ. 2001;270:141\u20138.","journal-title":"Sci Total Environ"},{"key":"403_CR24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1078\/0171-2985-00055","volume":"204","author":"A Ueki","year":"2001","unstructured":"Ueki A, Isozaki Y, Tomokuni A, Ueki H, Kusaka M, Tanaka S, et al. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain. Immunobiology. 2001;204:458\u201365.","journal-title":"Immunobiology"},{"key":"403_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02898059","volume":"7","author":"A Tomokuni","year":"2002","unstructured":"Tomokuni A, Otsuki T, Sakaguchi H, Isozaki Y, Hyodoh F, Kusaka M, et al. Detection of anti-topoisomerase I autoantibody in patients with silicosis. Environ Health Prev Med. 2002;7:7\u201310.","journal-title":"Environ Health Prev Med"},{"key":"403_CR26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/1529-0131(200102)44:2<491::AID-ANR74>3.0.CO;2-4","volume":"44","author":"A Ueki","year":"2001","unstructured":"Ueki A, Isozaki Y, Tomokuni A, Otsuki T, Hyodoh F, Sakaguchi H, et al. Is the anti-topoisomerase I autoantibody response associated with a distinct amino acid sequence in the HLA-DQbeta1 domain? Arthritis Rheum. 2001;44:491\u20132.","journal-title":"Arthritis Rheum"},{"key":"403_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2567.2005.02192.x","volume":"116","author":"A Takata-Tomokuni","year":"2005","unstructured":"Takata-Tomokuni A, Ueki A, Shiwa M, Isozaki Y, Hatayama T, Katsuyama H, et al. Detection, epitope-mapping and function of anti-Fas autoantibody in patients with silicosis. Immunology. 2005;116:21\u20139.","journal-title":"Immunology"},{"key":"403_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0065-2776(08)60672-0","volume":"57","author":"S Nagata","year":"1994","unstructured":"Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol. 1994;57:129\u201344.","journal-title":"Adv Immunol"},{"key":"403_CR29","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","volume":"267","author":"S Nagata","year":"1995","unstructured":"Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449\u201356.","journal-title":"Science"},{"key":"403_CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/1381612033392107","volume":"9","author":"JJ Bleesing","year":"2003","unstructured":"Bleesing JJ. Autoimmune lymphoproliferative syndrome (ALPS). Curr Pharm Des. 2003;9:265\u201378.","journal-title":"Curr Pharm Des"},{"key":"403_CR31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.cdd.4401190","volume":"10","author":"F Rieux-Laucat","year":"2003","unstructured":"Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 2003;10:124\u201333.","journal-title":"Cell Death Differ"},{"key":"403_CR32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0952-7915(98)80222-7","volume":"10","author":"ME Peter","year":"1998","unstructured":"Peter ME, Krammer PH. Mechanisms of CD95 (APO-1\/Fas)-mediated apoptosis. Curr Opin Immunol. 1998;10:545\u201351.","journal-title":"Curr Opin Immunol"},{"key":"403_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3260001","volume":"326","author":"GM Cohen","year":"1997","unstructured":"Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1\u201316.","journal-title":"Biochem J"},{"key":"403_CR34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2249.2002.01939.x","volume":"129","author":"A Ueki","year":"2002","unstructured":"Ueki A, Isozaki Y, Tomokuni A, Hatayama T, Ueki H, Kusaka M, et al. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol. 2002;129:556\u201361.","journal-title":"Clin Exp Immunol"},{"key":"403_CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1539\/joh.47.61","volume":"47","author":"A Ueki","year":"2005","unstructured":"Ueki A, Isozaki Y, Kusaka M. Anti-caspase-8 autoantibody response in silicosis patients is associated with HLA-DRB1, DQB1 and DPB1 alleles. J Occup Health. 2005;47:61\u20137.","journal-title":"J Occup Health"},{"key":"403_CR36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000051578","volume":"202","author":"H Ueki","year":"2001","unstructured":"Ueki H, Kohda M, Nobutoh T, Yamaguchi M, Omori K, Miyashita Y, et al. Antidesmoglein autoantibodies in silicosis patients with no bullous diseases. Dermatology. 2001;202:16\u201321.","journal-title":"Dermatology"},{"key":"403_CR37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00787226","volume":"19","author":"MR Alderson","year":"1998","unstructured":"Alderson MR, Lynch DH. Receptors and ligands that mediate activation-induced death of T cells. Springer Semin Immunopathol. 1998;19:289\u2013300.","journal-title":"Springer Semin Immunopathol"},{"key":"403_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.1997.tb01024.x","volume":"160","author":"JD Mountz","year":"1997","unstructured":"Mountz JD, Wu J, Zhou T, Hsu HC. Cell death and longevity: implications of Fas-mediated apoptosis in T-cell senescence. Immunol Rev. 1997;160:19\u201330.","journal-title":"Immunol Rev"},{"key":"403_CR39","doi-asserted-by":"crossref","first-page":"d12","DOI":"10.2741\/A112","volume":"1","author":"I Cascino","year":"1996","unstructured":"Cascino I, Papoff G, Eramo A, Ruberti G. Soluble Fas\/Apo-1 splicing variants and apoptosis. Front Biosci. 1996;1:d12\u20138.","journal-title":"Front Biosci"},{"key":"403_CR40","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.7510905","volume":"263","author":"J Cheng","year":"1994","unstructured":"Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263:1759\u201362.","journal-title":"Science"},{"key":"403_CR41","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/art.1780381205","volume":"38","author":"E Knipping","year":"1995","unstructured":"Knipping E, Krammer PH, Onel KB, Lehman TJ, Mysler E, Elkon KB. Levels of soluble Fas\/APO-1\/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. Arthritis Rheum. 1995;38:1735\u20137.","journal-title":"Arthritis Rheum"},{"key":"403_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF01541390","volume":"16","author":"Y Tokano","year":"1996","unstructured":"Tokano Y, Miyake S, Kayagaki N, Nozawa K, Morimoto S, Azuma M, et al. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus. J Clin Immunol. 1996;16:261\u20135.","journal-title":"J Clin Immunol"},{"key":"403_CR43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2249.1997.d01-901.x","volume":"107","author":"S Jodo","year":"1997","unstructured":"Jodo S, Kobayashi S, Kayagaki N, Ogura N, Feng Y, Amasaki Y, et al. Serum levels of soluble Fas\/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. Clin Exp Immunol. 1997;107:89\u201395.","journal-title":"Clin Exp Immunol"},{"key":"403_CR44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.1780400617","volume":"40","author":"K Nozawa","year":"1997","unstructured":"Nozawa K, Kayagaki N, Tokano Y, Yagita H, Okumura K, Hasimoto H. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum. 1997;40:1126\u20139.","journal-title":"Arthritis Rheum"},{"key":"403_CR45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.1997.tb08332.x","volume":"110","author":"A Tomokuni","year":"1997","unstructured":"Tomokuni A, Aikoh T, Matsuki T, Isozaki Y, Otsuki T, Kita S, et al. Elevated soluble Fas\/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin Exp Immunol. 1997;110:303\u20139.","journal-title":"Clin Exp Immunol"},{"key":"403_CR46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2567.1998.00509.x","volume":"94","author":"T Otsuki","year":"1998","unstructured":"Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Kawakami Y, et al. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology. 1998;94:258\u201362.","journal-title":"Immunology"},{"key":"403_CR47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-2478(00)00177-2","volume":"72","author":"T Otsuki","year":"2000","unstructured":"Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Isozaki Y, et al. Detection of alternatively spliced variant messages of Fas gene and mutational screening of Fas and Fas ligand coding regions in peripheral blood mononuclear cells derived from silicosis patients. Immunol Lett. 2000;72:137\u201343.","journal-title":"Immunol Lett"},{"key":"403_CR48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2249.2000.01132.x","volume":"119","author":"T Otsuki","year":"2000","unstructured":"Otsuki T, Tomokuni A, Sakaguchi H, Aikoh T, Matsuki T, Isozaki Y, et al. Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin Exp Immunol. 2000;119:323\u20137.","journal-title":"Clin Exp Immunol"},{"key":"403_CR49","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/153537020623100506","volume":"231","author":"T Otsuki","year":"2006","unstructured":"Otsuki T, Miura Y, Nishimura Y, Hyodoh F, Takata A, Kusaka M, et al. Alterations of Fas and Fas-related molecules in patients with silicosis. Exp Biol Med (Maywood). 2006;231:522\u201333.","journal-title":"Exp Biol Med (Maywood)"},{"key":"403_CR50","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/039463201002300414","volume":"23","author":"H Hayashi","year":"2010","unstructured":"Hayashi H, Miura Y, Maeda M, Murakami S, Kumagai N, Nishimura Y, et al. Reductive alteration of the regulatory function of the CD4(+)CD25(+) T cell fraction in silicosis patients. Int J Immunopathol Pharmacol. 2010;23:1099\u2013109.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"403_CR51","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-105-4-560","volume":"105","author":"WC Greene","year":"1986","unstructured":"Greene WC, Leonard WJ, Depper JM, Nelson DL, Waldmann TA. The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med. 1986;105:560\u201372.","journal-title":"Ann Intern Med"},{"key":"403_CR52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2141.1987.tb06156.x","volume":"67","author":"G Pizzolo","year":"1987","unstructured":"Pizzolo G, Chilosi M, Semenzato G. The soluble interleukin-2 receptor in haematological disorders. Br J Haematol. 1987;67:377\u201380.","journal-title":"Br J Haematol"},{"key":"403_CR53","first-page":"471","volume":"3","author":"B Zerler","year":"1991","unstructured":"Zerler B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells. 1991;3:471\u20139.","journal-title":"Cancer Cells"},{"key":"403_CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/MI.2005.121","volume":"2005","author":"AM Witkowska","year":"2005","unstructured":"Witkowska AM. On the role of sIL-2R measurements in rheumatoid arthritis and cancers. Mediat Inflamm. 2005;2005:121\u201330.","journal-title":"Mediat Inflamm"},{"key":"403_CR55","first-page":"407","volume":"4","author":"T Otsuki","year":"1999","unstructured":"Otsuki T, Ichihara K, Tomokuni A, Sakaguchi H, Aikoh T, Matsuki T, et al. Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis. Int J Mol Med. 1999;4:407\u201311.","journal-title":"Int J Mol Med"},{"key":"403_CR56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.imlet.2004.11.005","volume":"98","author":"P Wu","year":"2005","unstructured":"Wu P, Hyodoh F, Hatayama T, Sakaguchi H, Hatada S, Miura Y, et al. Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos\/chrysotile-A. Immunol Lett. 2005;98:145\u201352.","journal-title":"Immunol Lett"},{"key":"403_CR57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","volume":"101","author":"S Sakaguchi","year":"2000","unstructured":"Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000;101:455\u20138.","journal-title":"Cell"},{"key":"403_CR58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","volume":"182","author":"S Sakaguchi","year":"2001","unstructured":"Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, et al. Immunologic tolerance maintained by CD25\u00a0+\u00a0CD4\u00a0+\u00a0regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18\u201332.","journal-title":"Immunol Rev"},{"key":"403_CR59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.smim.2003.12.009","volume":"16","author":"DA Horwitz","year":"2004","unstructured":"Horwitz DA, Zheng SG, Gray JD, Wang JH, Ohtsuka K, Yamagiwa S. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin Immunol. 2004;16:135\u201343.","journal-title":"Semin Immunol"},{"key":"403_CR60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S. Naturally arising Foxp3-expressing CD25\u00a0+\u00a0CD4\u00a0+\u00a0regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345\u201352.","journal-title":"Nat Immunol"},{"key":"403_CR61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.175.1.32","volume":"175","author":"B Fritzsching","year":"2005","unstructured":"Fritzsching B, Oberle N, Eberhardt N, Quick S, Haas J, Wildemann B, et al. In contrast to effector T cells, CD4\u00a0+\u00a0CD25\u00a0+\u00a0FoxP3\u00a0+\u00a0regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J Immunol. 2005;175:32\u20136.","journal-title":"J Immunol"},{"key":"403_CR62","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2006-02-005660","volume":"108","author":"B Fritzsching","year":"2006","unstructured":"Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, Poschl J, et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood. 2006;108:3371\u20138.","journal-title":"Blood"},{"key":"403_CR63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1539\/joh.42.163","volume":"42","author":"T Otsuki","year":"2000","unstructured":"Otsuki T, Tomokuni A, Sakaguchi H, Hyodoh F, Kusaka M, Ueki A. Reduced expression of the inhibitory genes for Fas-mediated apoptosis in silicosis patients. J Occup Health. 2000;42:163\u20138.","journal-title":"J Occup Health"},{"key":"403_CR64","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/1547691X.2010.512579","volume":"7","author":"M Maeda","year":"2010","unstructured":"Maeda M, Nishimura Y, Kumagai N, Hayashi H, Hatayama T, Katoh M, et al. Altered regulation of the immune system caused by silica and asbestos. J Immunotoxicol. 2010;7:268\u201378.","journal-title":"J Immunotoxicol"},{"key":"403_CR65","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.imbio.2011.12.009","volume":"217","author":"S Lee","year":"2012","unstructured":"Lee S, Hayashi H, Maeda M, Chen Y, Matsuzaki H, Takei-Kumagai N, et al. Environmental factors producing autoimmune altered regulation\u2013chronic activation of T cells caused by silica exposure. Immunobiology. 2012;217:743\u20138.","journal-title":"Immunobiology"},{"key":"403_CR66","doi-asserted-by":"crossref","unstructured":"Takei-Kumagai N, Lee S, Matsuzaki H, Hayashi H, Maeda M, Nishimura Y, et al. Immunological effects of silica. In: Kretsinger RH, Uversky VN, Permyakov EA, editors. Encyclopedia of metalloproteins. New York: Springer Science\u00a0+\u00a0Business Media; 2013. pp. 1965\u201371.","DOI":"10.1007\/978-1-4614-1533-6_445"},{"key":"403_CR67","doi-asserted-by":"crossref","unstructured":"Kumagai N, Hayashi H, Maeda M, Miura Y, Nishimura Y, Matsuzaki H, et al. Immunological effects of silica and related altered regulation of autoimmunity. In: Mavragani CP, editor. Autoimmune disorders-pathogenetic aspects. Croatia: InTech Open Access Publisher; 2011. doi: 10.5772\/19218 .","DOI":"10.5772\/19218"},{"key":"403_CR68","doi-asserted-by":"crossref","unstructured":"Lee S, Maeda M, Hayashi H, Matsuzaki H, Kumagai-Takei N, Nishimura Y, et al. Immunostimulation by silica particles and the development of autoimmune altered regulation. In: Duc H, editor. Immunostimulation. Croatia: InTech Open Access Publisher; 2014. doi: 10.5772\/57544 .","DOI":"10.5772\/57544"},{"key":"403_CR69","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","volume":"24","author":"CT Weaver","year":"2006","unstructured":"Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24:677\u201388.","journal-title":"Immunity"},{"key":"403_CR70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jcp.20973","volume":"211","author":"Y Bi","year":"2007","unstructured":"Bi Y, Liu G, Yang R. Th17 cell induction and immune regulatory effects. J Cell Physiol. 2007;211:273\u20138.","journal-title":"J Cell Physiol"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12199-014-0403-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12199-014-0403-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12199-014-0403-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T22:36:53Z","timestamp":1565735813000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12199-014-0403-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,19]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["403"],"URL":"https:\/\/doi.org\/10.1007\/s12199-014-0403-9","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"value":"1342-078X","type":"print"},{"value":"1347-4715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,19]]}}}